Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry

Molecule targeting therapy using somatostatin (SS) analogues has become a widely accepted modality to treat neuroendocrine tumors (NETs), particularly gastrointestinal (GI) and pancreatic endocrine tumors. On the other hand, little is known about the expression of somatostatin receptor (SSTR) subtyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizutani, Gou, Nakanishi, Yoko, Watanabe, Noriko, Honma, Taku, Obana, Yukari, Seki, Toshimi, Ohni, Sumie, Nemoto, Norimichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Society of Histochemistry and Cytochemistry 2012
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395302/
https://www.ncbi.nlm.nih.gov/pubmed/22829710
http://dx.doi.org/10.1267/ahc.12006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395302/
https://www.ncbi.nlm.nih.gov/pubmed/22829710
http://dx.doi.org/10.1267/ahc.12006

Ejemplares similares